By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Anti-CTLA-4 monoclonal antibodies > Yervoy
Anti-CTLA-4 monoclonal antibodies

Yervoy

https://themeditary.com/drug/yervoy-825.html
Medically Reviewed by Melisa Puckey, BPharm TheMediTary.Com | Reviewed: Jul 12, 2023  Additional Content by TheMediTary.Com

Generic name: ipilimumab [ ip-i-lim-ue-mab ]

Drug class: Anti-CTLA-4 monoclonal antibodies

Dosage form: intravenous infusion (50 mg/10 ml, 200 mg/40 ml)

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Ipilimumab

Contents
Uses Warnings Before Taking Dosage Side effects Interactions
  • Yervoy (Ipilimumab [ ip-i-lim-ue-mab ])-medicine-50 mg/10 mL injection Yervoy 50 mg/10 mL injection (medicine)
  • Yervoy (Ipilimumab [ ip-i-lim-ue-mab ])-medicine-200 mg/40 mL injection Yervoy 200 mg/40 mL injection (medicine)
  • View all images

What is Yervoy?

Yervoy (ipilimumab) is a monoclonal antibody used to treat specific cancers including melanoma, non-small cell lung cancer (NSCLC), pleural mesothelioma, esophageal cancer, kidney cancer (RCC), liver cancer, or colorectal cancer.  Yervoy can be used alone or combined with another cancer medicine such as Opdivo (nivolumab).

Yervoy is an immunotherapy that blocks a protein (antigen) that can stop your immune system from working properly and attacking cancer cells. When Yervoy has blocked the protein (CTLA-4) the immune system is able to find and kill the cancer cells. 

Yervoy is from the class of medicines called immune checkpoint inhibitors, and because it blocks the T-lymphocyte antigen 4 (CTLA-4), it is called a CTLA-4 inhibitor. 

Yervoy became an FDA-approved medicine on August 18, 2010, for treating advanced melanoma, and since then, the FDA approval has been extended to include a range of cancers.

Warnings

Serious and sometimes fatal reactions may occur during treatment with this medicine or months after your last dose. Call your doctor at once if you have: chest pain, cough, shortness of breath, vision changes, severe muscle pain or weakness, diarrhea and severe stomach pain, blood in your stools, little or no urinating, swelling, bruising or bleeding, dark urine, yellowing of the skin or eyes, confusion, hallucinations, a seizure, skin blistering, or a hormonal disorder (frequent headaches, feeling light-headed, increased thirst or urination, feeling cold, weight gain or loss).

Before you receive Yervoy, tell your doctor if you have liver damage, an autoimmune disorder such as lupus or sarcoidosis, Crohn's disease, ulcerative colitis, or if you have received an organ transplant.

Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.

How should I use Yervoy

Yervoy is given as an infusion into a vein (IV infusion). A healthcare provider will give you this injection.

This medicine must be given slowly, and the infusion can take 30-90 minutes to complete.

Yervoy is usually given once every 3 to 6 weeks, depending on which type of cancer is being treated. Your other cancer medications may be given more often. Your doctor will determine how long to treat you with all medicines.

Yervoy can be used alone or combined with other cancer medicines such as Opdivo (Nivolumab). 

You may be given other medications to treat or prevent certain side effects.

You may need frequent medical tests and your cancer treatments may be delayed based on the results.

Yervoy is available as an Injection: 50 mg/10 mL (5 mg/mL) or 200 mg/40 mL (5 mg/mL) in a single-dose vial. 

Detailed Yervoy dosage information
Yervoy Dosage information (more detail)

Before Taking

You should not receive this medicine if you are allergic to the active ingredient ipilimumab or any of the inactive ingredients.

To make sure Yervoy is safe for you, tell your doctor if you have ever had:

  • liver problems;
  • an autoimmune disorder (lupus, sarcoidosis, Crohn's disease, ulcerative colitis);
  • an organ transplant or stem cell transplant; or
  • a nerve-muscle disorder, such as myasthenia gravis, or Guillain-Barre syndrome.

This medicine is not approved for use by anyone younger than 12 years old and for some types of cancer, it is used only in adults.

Pregnancy

Yervoy may harm an unborn baby. 

You may need to have a negative pregnancy test before starting this treatment. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 3 months after your last dose. Tell your doctor if you become pregnant.

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of ipilimumab on the baby.

Breastfeeding

Do not breastfeed while using this medicine, and for at least 3 months after your last dose.

Yervoy pregnancy and breastfeeding warnings (more detail)

What happens if I miss a dose?

Call your doctor for instructions if you miss a chemotherapy appointment.

What happens if I overdose?

Since this medicine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid while using Yervoy?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Yervoy side effects

Common Yervoy side effects

The most common side effects include:

  • fever, cough, shortness of breath;
  • nausea, vomiting, stomach pain, loss of appetite;
  • diarrhea, constipation;
  • weight loss;
  • hormonal problems;
  • rash or itching;
  • headache, dizziness, tiredness;
  • sleep problems (insomnia); or
  • pain in your muscles, joints, or bones.

Serious Yervoy side effects

Get emergency medical help if you have signs of an allergic reaction to this medicine (hives, difficulty breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Some side effects may occur during the injection. Tell your caregiver if you feel dizzy, light-headed, short of breath, itchy, tingly, chilled, or feverish.

Serious and sometimes fatal reactions may occur during treatment with this medicine or months after your last dose. Call your doctor right away if you have symptoms such as:

  • severe or ongoing diarrhea, severe stomach pain, bloody or tarry stools;
  • fever, swollen glands, body aches;
  • new or worsening skin rash, itching, or blistering;
  • painful sores in mouth or nose, throat, or genital area;
  • chest pain, irregular heartbeats;
  • severe muscle weakness, ongoing pain in your muscles or joints;
  • numbness or tingling in your hands or feet;
  • vision problems, eye pain or redness;
  • lung problems - new or worsening cough, chest pain, feeling short of breath;
  • kidney problems - little or no urination, swelling in your feet or ankles, blood in your urine;
  • liver problems - right-sided upper stomach pain, tiredness, bruising or bleeding, dark urine, yellowing of your skin or eyes;
  • signs of a hormonal disorder - frequent or unusual headaches, lack of energy, dizziness, fainting, mood or behavior changes, increased thirst or urination, feeling cold, weight gain, or weight loss; or
  • symptoms of brain swelling - confusion, headache, memory problems, hallucinations, neck stiffness, drowsiness, seizure (convulsions).

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Yervoy Side Effects

What other drugs will affect Yervoy?

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. 

More about Yervoy (Ipilimumab [ ip-i-lim-ue-mab ])

Dosage information
Yervoy Side Effects
During pregnancy
Yervoy Prescribing Information
Drug images
Side effects
Drug class: Anti-CTLA-4 monoclonal antibodies

Related treatment guides

Renal Cell Carcinoma
Melanoma, Metastatic
Malignant Pleural Mesothelioma
Colorectal Cancer
Melanoma
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by